United Kingdom
News & Events
Upcoming Events
EMMAC Life Sciences Group to Present at The Canaccord Genuity 4th Annual Cannabis Conference
Tuesday 12th May 2020 – Antonio Costanzo, Chief Executive Officer and Thomas Ellen, Chief Financial Officer, EMMAC Life Sciences Group to present at The Canaccord
Press Releases
EMMAC Life Sciences Group provides Corporate Update
04 November 2020, London. EMMAC Life Sciences Group (“EMMAC” or the “Group” or the “Company”), Europe’s largest independent cannabis company, provides the following corporate
EMMAC Life Sciences Group announces UK manufacture of medical cannabis
16 October 2020, London. EMMAC Life Sciences Group (“EMMAC” or the “Group” or the “Company”), Europe’s largest independent cannabis company, is pleased to announce
EMMAC secures GDP licence for Swiss pharmaceutical entity, EMMAC SAGL
18 August 2020, London. EMMAC Life Sciences Group, Europe’s largest independent cannabis company, is pleased to announce that EMMAC SAGL, the Group’s pharmaceutical entity
Medalchemy receives licence for cultivation of medical cannabis. Spanish EU GMP Facility now has licences to cultivate, extract and manufacture cannabis extract
28 July 2020, London. EMMAC Life Sciences Group, Europe’s largest independent cannabis company, is pleased to announce that Medalchemy, the Group’s Good Manufacturing Practice
Andina Acquisition Corp. III and EMMAC Life Sciences Limited Announce Signing of Non-Binding Letter of Intent for Business Combination
22nd July 2020 EMMAC is the Largest Independent European Cannabis Company with Low-Cost Cultivation, EU-GMP Manufacturing and Processing, and an Import / Distribution Network
EMMAC to manufacture product for COVID-19 clinical trial
26 May 2020, London. EMMAC Life Sciences Group, Europe’s leading independent cannabis company, is pleased to announce that Medalchemy, the Group’s GMP certified manufacturing
